Antibiotic use before cancer treatment cuts survival time study
Taking antibiotics in the month prior to starting immunotherapy for cancer can lessen the chance of survival, an important finding given the... Read More
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study
In a trial involving 949 patients with 40 tumor types, including gastric cancer, a blood test from Guardant Health was as good... Read More
Updated Clinical Data from Combination of Margetuximab and Pembrolizumab in Gastric Cancer Presented at 2019 ASCO Gastrointestinal Cancers Symposium
“We continue to be very encouraged by the tolerability and antitumor activity of margetuximab with an anti-PD-1 mAb, an investigational, chemotherapy-free approach... Read More
A Conceptual Overview of Targeted Therapy in GI Cancers
Watch this PracticeUpdate video for an overview of gastric cancer treatments (register for free to view).
ENA NEWS: Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
New research published in European Cancer finds gastric cancer patients respond well to a new anti-HER2 drug, which binds to two distinct... Read More
Dr. Iqbal on Second- and Third-Line Therapies in Gastric Cancer
Dr. Syma Iqbal, Keck School of Medicine at University of Southern California, discusses second- and third-line therapies in gastric cancer via OncLive.
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
Have you heard of tumor mutation burdens? Recently published in JAMA, researchers discovered gastric cancer tissue samples with a MUC16 gene mutation... Read More
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists
Scientists review the emerging trends in the use of antagonists to proteins PD-1/PD-L1 and gastrointestinal tumors.
Checkpoint inhibitors for the treatment of metastatic gastric cancers
Researchers evaluate early-phase and late-phase trials of immunotherapy in advanced gastric cancer. Read the full article in Cancer Treatment Reviews, Evolution of checkpoint... Read More
New Drugs, Immuno-Oncology Advances Gastric Cancer Treatment Paradigm
Immuno-oncology and the classification of subtypes of gastric cancer could greatly advance treatment efficacy and variation, according to Manish A. Shah, MD.